IGF1R and Ewing sarcoma: A subset of patients with Ewing's sarcoma have remarkable responses to insulin-like growth factor-1 receptor (IGF-1R) inhibitors [4]–[9], including the fully human anti-IGF-1R antibody, R1507 [4].